Draft:ResearchSat
 | Review waiting, please be patient.
This may take 2 months or more, since drafts are reviewed in no specific order. There are 2,170 pending submissions waiting for review.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
Reviewer tools
|
Comment: In accordance with Wikipedia's Conflict of interest guideline, I disclose that I have a conflict of interest regarding the subject of this article. RstRaviteja (talk) 13:40, 22 June 2026 (UTC)
ResearchSat Pty Ltd is an Australian space biotechnology company that develops payloads and experiment platforms for biological research in microgravity. Established in 2018, the company has conducted suborbital experiments and contributed hardware to research with RMIT University.[1][2]
History
ResearchSat was founded in 2018 by aerospace engineers Raviteja Duggineni and Jibin Jeffrey Dhanaraj. The company was initially bootstrapped and later developed a modular research payload intended to host biological experiments during spaceflight.[1][3] In 2023, ResearchSat acquired South Australian high-altitude balloon operator Up&Up Space. The acquisition added a lower-cost platform for testing components in near-space conditions before suborbital or orbital missions.[1]
Missions and research
In November 2022, ResearchSat launched its ADI-Alpha payload aboard a sounding rocket from the Esrange Space Center in Sweden. The payload reached an altitude of approximately 260 km (160 mi) and experienced about six minutes of microgravity before returning to Earth.[4]
ResearchSat later collaborated with RMIT University on a study of Bacillus subtilis spores exposed to launch acceleration, short-duration microgravity and re-entry deceleration. ResearchSat and RMIT developed a custom three-dimensional-printed sample holder for the flight. The study, published in npj Microgravity in 2025, found no observable change in the spores' growth or structure after the flight.[2][5]
In February 2024, two payloads delivered by ResearchSat flew on the German Aerospace Center's MAPHEUS-14 sounding rocket. The Australian Space Agency described the payloads as a biological-cell monitoring experiment and a contingency communications unit for small satellites. The rocket reached approximately 265 km (165 mi) during the flight.[6]
In 2026, a ResearchSat-led project with AltData and AICRAFT received A$150,000 from the South Australian Space Collaboration and Innovation Fund. The project was funded to combine microgravity experiment data with artificial-intelligence models for pharmaceutical research.[7]
External links
References
- ^ a b c Simmons, David (27 June 2023). "Local space company to hit new heights". InDaily. Retrieved 22 June 2026.
- ^ a b Ratcliffe, Aeden (6 October 2025). "Rocket test proves bacteria survive space launch and re-entry unharmed". RMIT University. Retrieved 22 June 2026.
- ^ Blandis, Eva (23 June 2022). "A start-up blasts off with microgravity research at the forefront of its mission". Lot Fourteen. Retrieved 22 June 2026.
- ^ "Space medtech startup takes clinical research to new heights to improve human health on Earth…and beyond!". Lot Fourteen. 30 November 2022. Retrieved 22 June 2026.
- ^ Yang, E. (2025). "Effects of extreme acceleration, microgravity, and deceleration on Bacillus subtilis onboard a suborbital space flight". npj Microgravity. 11. doi:10.1038/s41526-025-00526-4.
- ^ "Aussie experiments launch into space". Australian Space Agency. 28 February 2024. Retrieved 22 June 2026.
- ^ "South Australian space innovation to unlock medical breakthroughs" (Press release). Defence Innovation Partnership. 12 February 2026. Retrieved 22 June 2026.
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.